Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-25 @ 1:47 AM
NCT ID:
NCT06395194
Eligibility Criteria:
Inclusion Criteria:
* hypertension, and predefined combinations of risk factors, including:
* age
* male gender
* the presence of electrocardiographic left ventricular hypertrophy (LVH, determined by Cornell voltage-duration product or Sokolow-Lyon voltage criteria with or without a strain pattern)
* serum creatinine ≥150 μmol/l
* proteinuria (positive urine dipstick at two occasions)
* type 2 diabetes mellitus
* verified coronary, cerebrovascular, or peripheral artery disease
Exclusion Criteria:
* pregnancy
* renal artery stenosis
* myocardial infarction, percutaneous coronary intervention, or coronary artery bypass surgery during last three months
* medically relevant cardiac valvular disease
* cerebrovascular events last 3 months
* severe hepatic disease
* severe chronic kidney failure (serum creatinine \>3.0 mg/dl, \>265 µmol/L)
* congestive heart failure requiring angiotensin converting enzyme inhibitor (ACEI)
* use of beta-blocker for both coronary artery disease and hypertension
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Maximum Age:
85 Years
Study:
NCT06395194
Study Brief:
Protocol Section:
NCT06395194